Last reviewed · How we verify

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase 3 active Small molecule

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen is a Aromatase inhibitor, Selective estrogen receptor modulator Small molecule drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. It is currently in Phase 3 development for Treatment of hormone receptor-positive metastatic breast cancer, Adjuvant treatment of hormone receptor-positive breast cancer.

Letrozole and Anastrozole are non-steroidal, selective aromatase inhibitors, while Tamoxifen is a selective estrogen receptor modulator.

Letrozole and Anastrozole are non-steroidal, selective aromatase inhibitors, while Tamoxifen is a selective estrogen receptor modulator. Used for Treatment of hormone receptor-positive metastatic breast cancer, Adjuvant treatment of hormone receptor-positive breast cancer.

At a glance

Generic nameTQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug classAromatase inhibitor, Selective estrogen receptor modulator
TargetAromatase, Estrogen receptor
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

These drugs work by inhibiting the aromatase enzyme, which is responsible for converting androgens to estrogens, thereby reducing estrogen levels in the body. Tamoxifen, on the other hand, binds to estrogen receptors, blocking the action of estrogen in breast tissue.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen

What is TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen is a Aromatase inhibitor, Selective estrogen receptor modulator drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., indicated for Treatment of hormone receptor-positive metastatic breast cancer, Adjuvant treatment of hormone receptor-positive breast cancer.

How does TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen work?

Letrozole and Anastrozole are non-steroidal, selective aromatase inhibitors, while Tamoxifen is a selective estrogen receptor modulator.

What is TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen used for?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen is indicated for Treatment of hormone receptor-positive metastatic breast cancer, Adjuvant treatment of hormone receptor-positive breast cancer.

Who makes TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen is developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (see full Chia Tai Tianqing Pharmaceutical Group Co., Ltd. pipeline at /company/chia-tai-tianqing-pharmaceutical-group-co-ltd).

What drug class is TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen in?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen belongs to the Aromatase inhibitor, Selective estrogen receptor modulator class. See all Aromatase inhibitor, Selective estrogen receptor modulator drugs at /class/aromatase-inhibitor-selective-estrogen-receptor-modulator.

What development phase is TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen in?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen is in Phase 3.

What are the side effects of TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen?

Common side effects of TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen include Hot flashes, Vaginal discharge, Nausea, Diarrhea, Musculoskeletal pain.

What does TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen target?

TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen targets Aromatase, Estrogen receptor and is a Aromatase inhibitor, Selective estrogen receptor modulator.

Related